(Q41830265)

12 October 2017

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression (English)

1 reference

lymphoproliferative disorders

12 October 2017

1 reference

1 reference

16

T E Starzl

1 reference

12 October 2017

15

J J Fung

1 reference

12 October 2017

10

S Lombardozzi-Lane

1 reference

12 October 2017

R Shapiro

1

1 reference

12 October 2017

M Nalesnik

2

1 reference

12 October 2017

J McCauley

3

1 reference

12 October 2017

S Fedorek

4

1 reference

12 October 2017

M L Jordan

5

1 reference

12 October 2017

V P Scantlebury

6

1 reference

12 October 2017

A Jain

7

1 reference

12 October 2017

C Vivas

8

1 reference

12 October 2017

D Ellis

9

1 reference

12 October 2017

P Randhawa

11

1 reference

12 October 2017

J Johnston

12

1 reference

12 October 2017

T R Hakala

13

1 reference

12 October 2017

R L Simmons

14

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

12 October 2017

1 reference

12 October 2017

68

1 reference

12 October 2017

12

1 reference

12 October 2017

1851-1854

1 reference

Tacrolimus in pediatric renal transplantation: a review

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Pediatric renal transplantation under tacrolimus-based immunosuppression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

HLA and cross-reactive antigen group matching for cadaver kidney allocation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Tacrolimus in pediatric renal transplantation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Tacrolimus in renal transplantation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Malignant lymphomas in transplantation patients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

FK 506 in clinical kidney transplantation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086425

Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children

18 August 2018

1 reference

12 December 2020

Post-transplant lymphoproliferative disorder

1 reference

12 December 2020

Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients

1 reference

12 December 2020

Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop

1 reference

12 December 2020

10.1097/00007890-199912270-00006

Identifiers

DOI

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

10628763

1 reference